Inventor · disambiguated record
Geoffrey Richard Heintzelman
Also filed as: HEINTZELMAN GEOFFREY R · HEINTZELMAN GEOFFREY RICHARD
18 granted patents·6 pending applications·466 citations·filing 2002–2019
96Inventor score
Files withAERIE PHARMACEUTICALS INC8DELONG MITCHELL A5HEINTZELMAN GEOFFREY R4ORTHO MCNEIL PHARM INC4JANSSEN PHARMACEUTICA NV1
Top patents by PatentIndex Score
24 records- 0198US7671205B26-aminoisoquinoline compoundsAERIE PHARMACEUTICALS INC·Filed 2007·Granted Mar 2, 2010·61 cites·3 claims
- 0297US10899714B26-aminoisoquinoline compoundsAERIE PHARMACEUTICALS INC·Filed 2019·Granted Jan 26, 2021·10 cites·24 claims
- 0397US8921392B26-aminoisoquinoline compoundsAERIE PHARMACEUTICALS INC·Filed 2012·Granted Dec 30, 2014·38 cites·12 claims
- 0497US8455647B26-aminoisoquinoline compoundsDELONG MITCHELL A·Filed 2011·Granted Jun 4, 2013·44 cites·3 claims
- 0597US8455513B26-aminoisoquinoline compoundsDELONG MITCHELL A·Filed 2007·Granted Jun 4, 2013·44 cites·21 claims
- 0697US8357699B26-aminoisoquinoline compoundsAERIE PHARMACEUTICALS INC·Filed 2011·Granted Jan 22, 2013·42 cites·19 claims
- 0797US8034943B26-aminoisoquinoline compoundsAERIE PHARMACEUTICALS INC·Filed 2010·Granted Oct 11, 2011·49 cites·4 claims
- 0896US8455514B26-and 7-amino isoquinoline compounds and methods for making and using the sameDELONG MITCHELL A·Filed 2008·Granted Jun 4, 2013·43 cites·14 claims
- 0996US7468373B2Arylindenopyridines and arylindenopyrimidines and related therapeutic and prophylactic methodsORTHO MCNEIL PHARM INC·Filed 2005·Granted Dec 23, 2008·32 cites·4 claims
- 1095US8871757B26-and 7-amino isoquinoline compounds and methods for making and using the sameDELONG MITCHELL A·Filed 2010·Granted Oct 28, 2014·36 cites·48 claims
- 1192US9365518B26-aminoisoquinoline compoundsAERIE PHARMACEUTICALS INC·Filed 2014·Granted Jun 14, 2016·10 cites·21 claims
- 1291US10472327B26-aminoisoquinoline compoundsAERIE PHARMACEUTICALS INC·Filed 2017·Granted Nov 12, 2019·6 cites·13 claims
- 1390US9890123B26-aminoisoquinoline compoundsAERIE PHARMACEUTICALS INC·Filed 2016·Granted Feb 13, 2018·5 cites·11 claims
- 1487US6958328B2Arylindenopyridines and related therapeutic and prophylactic methodsORTHO MCNEIL PHARM INC·Filed 2002·Granted Oct 25, 2005·18 cites·35 claims
- 1586US7345052B2Arylindenopyridines and arylindenopyrimidines and related therapeutic and prophylactic methodsORTHO MCNEIL PHARM INC·Filed 2005·Granted Mar 18, 2008·4 cites·5 claims
- 1684US7754730B2Arylindenopyridines and arylindenopyrimidines and related therapeutic and prophylactic methodsORTHO MCNEIL PHARM INC·Filed 2006·Granted Jul 13, 2010·3 cites·2 claims
- 1782US6903109B2Arylindenopyridines and related therapeutic and prophylactic methodsORTHO MUNIEL PHARMACEUTICAL IN·Filed 2002·Granted Jun 7, 2005·19 cites·24 claims
- 1881US7759356B2Arylindenopyridines and arylindenopyrimidines and related therapeutic and prophylactic methodsJANSSEN PHARMACEUTICA NV·Filed 2008·Granted Jul 20, 2010·2 cites·4 claims
- 1958US2012135984A1Dual-action inhbitors and methods of using sameDELONG MITCHELL A·Filed 2010·Application pending·0 cites
- 2056US2005277637A1Arylindenopyridines and related therapeutic and prophylactic methodsHEINTZELMAN GEOFFREY R·Filed 2005·Application pending·0 cites
- 2156US2006009481A1Arylindenopyridines and related therapeutic and prophylactic methodsHEINTZELMAN GEOFFREY R·Filed 2005·Application pending·0 cites
- 2255US2006154949A1Arylindenopyridines and related therapeutic and prophylactic methodsHEINTZELMAN GEOFFREY R·Filed 2005·Application pending·0 cites
- 2352US2004127510A1Arylindenopyridines and arylindenopyrimidines and related therapeutic and prophylactic methodsFiled 2003·Application pending·0 cites
- 2442US2005239782A1Arylindenopyridines and related therapeutic and prophylactic methodsHEINTZELMAN GEOFFREY R·Filed 2005·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Geoffrey Richard Heintzelman files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →